TABLE 6

Comparison of Dose per Unit Administered Activity Between 18F-RGD-K5 and Other 18F-Based Imaging Agents

DoseRGD-K5, 1-h bladder-voiding intervalRGD-K5, 4.8-h bladder-voiding interval18F-FDG, 4.8-h bladder-voiding intervalGalacto-RGD, 2-h bladder-voiding intervalHX4, 1-h bladder-voiding intervalHX4, 4.8-h bladder-voiding interval
Total body dose (μGy/MBq)7.89.6115.34810
Effective dose (μSv/MBq)15311918.681427